Page 618 - medicina-integrativa_compress

626 PARTE II, SECCIÓN 9 OBSTETRICIA/GINECOLOGÍA

BIBLIOGRAFÍA 26. Zhu BT, Conney AH: Is 2-methoxyestradiol an endogenous estrogen
metabolite that inhibits mammary carcinogenesis? Cancer Res
1. Lethaby A, Vollerhover B: Fibroids (uterine myomatosis, 58:2269-2277, 1998.
leiomyomas). Clin Evid Concise 11:490-493, 2004. 27. Schellenberg R: Treatment for the premenstrual syndrome with
2. Mendelsohn RS: Malepractice—How Doctors Manipulate Women. agnus castus fruit extract: Prospective, randomized, placebo
Chicago, Contemporary Books, 1981. controlled study. BMJ 322:134-137, 2001.
3. Lampe A, Doering S, Pumpold G, et al: Childhood pain syndromes 28. Wuttke W, Jarry H, Christoffel V, et al: Chaste tree (Vitex agnus-
and their relation to childhood abuse and stressful life events. castus)—pharmacology and clinical indications. Phytomedicine
J Psychosom Res 54:361-367, 2003. 10:348-357, 2003.
4. Chez R: The etiology and treatment of uterine fibroids. Altern Ther 29. Simmons CA: The relief of pain in spasmodic dysmenorrhea by
8:32-33, 2002. bromelain. Lancet 2(7051):827, 1958.
5. Das UN: Is obesity an inflammatory condition? Nutrition 17: 30. Kee WH, Tan SL, Lee V, Salmon YM: The treatment of breast
953-966, 2001. engorgement with serrapeptase: A randomized double-blind
6. Chiu KC, Chu A, Vay LWG, Saad MF: Hypovitaminosis D is controlled trial. Singapore Med J 30:48-54, 1989.
associated with insulin resistance and beta cell dysfunction. 31. Folkman J: Tumor angiogenesis: Therapeutic implications. N Engl J
Am J Clin Nutr 79:820-825, 2004. Med 285:1182-1186, 1971.
7. Nesby-O’Dell S, Scanlon KS, Cogswell ME, et al: 32. Riordan NH, Meng X, Riordan HD: Anti-angiogenic, anti-tumor
Hypovitaminosis D prevalence and determinants among Afro and immunostimulatory effects of a non-toxic plant extract (PGM).
American and white women of reproductive age: Third National Paper presented at Comprehensive Cancer Care 2000, June 2000,
Health and Nutrition Examination Survey, 1988-1994. Am J Clin Arlington, Virginia.
Nutr 76:187-192, 2002. 33. Fugh-Berman A, Kronenberg F: Complementary and alternative
8. Holick MF: Vitamin D: Importance in the prevention of cancers, medicine (CAM) in reproductive-age women: A review of randomized
type 1 diabetes, heart disease, and osteoporosis. Am J Clin Nutr clinical controlled trials. Reprod Toxicol 17:137-152, 2003.
79:362-371, 2004. 34. Zhongli, Shurong: TCM Rx of uterine leiomyomata:
9. Stewart EA, Nowak RA: Leiomyomata-related bleeding: A classic http://library.ust.hk/guides/tcm/tcm-ust.html
hypothesis updated for the molecular era. Human Reprod Update 35. Mehl-Madrona L: Complementary medicine treatment of
2:295-306, 1996. uterine fibroids: A pilot study. Altern Ther 8:34-46, 2002.
10. Lee JR, Hanley J, Hopkins V: What your doctor may not tell you 36. Lithgow DM, Politzer WM: Vitamin A in the treatment of
about premenopause. New York, Warner Books, 1999. menorrhagia. S Afr Med J 51:191-199, 1977.
11. Minton JP, Walaszek Z, Hanausek-Walaszek M, Webb TE: 37. Cohen JD, Rubin HW: Functional menorrhagia: Treatment with
β-glucuronidase levels in patients with fibrocystic breast disease. bioflavonoids and vitamin C. Curr Ther Res 2:539, 1960.
Breast Cancer Res Treat 8:217-222, 1986. 38. Kleijnen J, Ter Riet G, Knipchild P: Vitamin B6 in the treatment
12. Bland J: The 20-Day Rejuvenation Diet Program. Lincolnwood, Ill, of the premenstrual syndrome—a review. Br J Obstet Gynaecol
Keats, 1997. 97:847-852, 1990.
13. Reaven GM: Pathophysiology of insulin resistance in human disease. 39. Hudgins AP: Vitamins P, C and niacin for dysmenorrheal therapy.
Physiol Rev 75:473-486, 1995. West J Surg 62:610-611, 1954.
14. Singh A, Hamilton-Gairley D, Koistinen R, et al: Effect of 40. Roland SG: Ultraviolet light may contribute to geographic and racial
insulin-like growth factor-type 1 (IGF-1) and insulin on the secretion blood pressure differences. Hypertension 30:150-156, 1997.
of sex hormone binding globulin and IGF-1 binding protein (IBP-1) 41. Cantorna MT: Vitamin D and autoimmunity: Is vitamin D status
by human hepatoma cells. J Endocrinol 124:R1-R3, 1990. an environmental factor affecting autoimmune disease prevalence?
15. Muti P, Bradlow HL, Micheli A, et al: Estrogen metabolism and risk Proc Soc Biol Med 223:230-233, 2000.
of breast cancer: A prospective study of the 2:16alpha-hydroxyestrone 42. Taymor ML, Sturgis SH, Yahia C: The etiological role of chronic
ratio in premenopausal and postmenopausal women. Epidemiology iron deficiency in production of menorrhagia. JAMA 187:323-327,
11:635-640, 2000. 1964.
16. Walle T, Otake Y, Galijatkovic A, et al: Induction of UDP- 43. Facchinetti F, Borella P, Sances G, et al: Oral magnesium
glucuronosyltransferase UGT1Ai by the flavonoid chrysin successfully relieves premenstrual mood changes. Obstet Gynecol
in the human hepatoma cell line hep G2. Drug Metab Dispos 28: 78:177-181, 1991.
1077-1082, 2000. 44. Goodale IL, Domar AD, Benson H: Alleviation of premenstrual
17. Knight DC, Eden JA: A review of the clinical effects of syndrome symptoms with the relaxation response. Obstet Gynecol
phytoestrogens. Obstet Gynecol 87:897-904, 1996. 75:649-655, 1990.
18. Gailbraith RA, Michnovicz JJ: The effects of cimetidine on the 45. Domar AD, Seibel MM, Benson H: The mind-body program for
oxidative metabolism of estradiol. N Engl J Med 321:269-274, 1989. infertility: A new behavioral treatment approach for women with
19. Murphy AA, Kettel LM, Morales AJ, Yen SSC: Regression of uterine infertility. Fertil Steril 53:246-249, 1990.
leiomyomata in response to the antiprogesterone RU486. J Clin 46. Nakamura Y, Yoshimura Y, Yamada H, et al: Treatment of uterine
Endocrinol Metab 76:513-517, 1993. leiomyomata with a luteinizing hormone agonist: The possibility of
20. Goldin BR, Alderkreutz H, Dwyer JT, et al: Effect of diet on nonsurgical management in selected perimenopausal women.
excretion of estrogens in pre and postmenopausal women. Cancer Fertil Steril 55:900-905, 1991.
Res 41:3771-3773, 1981. 47. Rauramo I, Elo I, Istre O: Long-term treatment of menorrhagia
21. Harel Z, Biro FM, Kottenhahn RK, Rosenthal SL: Supplementation with levonorgestrel intrauterine system versus endometrial
with omega-3 polyunsaturated fatty acids in the management of resection. Obstet Gynecol 104:1314-1321, 2004.
dysmenorrhea in adolescents. Am J Obstet Gynecol 174:1335-1338, 48. Goodman A: Progesterone therapy in uterine fibromyoma. J Clin
1996. Endocrinol Metab 6:402, 1946.
22. Goodman MT, Wilkens LR, Hankin JH, et al: Association of soy and 49. Montz FJ, Bristow RE, Tomacruz R, Kurman RJ: Intrauterine
fiber consumption with the risk of endometrial cancer. Am J progesterone treatment of early endometrial cancer. Am J Obstet
Epidemiol 146:294-306, 1997. Gynecol 186:651-657, 2002.
23. Nagata C: Decreased serum estradiol concentration associated with 50. Hindley JT, Law PA, Hickey M, et al: Clinical outcomes following
high dietary intake of soy products in premenopausal Japanese percutaneous magnetic resonance image guided laser ablation of
women. Nutr Cancer 138:863-870, 1997. symptomatic uterine fibroids. Human Reprod 17:10:2737-2741,
24. Brzezinski A, Debi A: Phytoestrogens: The natural selective estrogen 2002.
modulators? Eur J Obstet Gynecol Reprod Biol 85:47-51, 1999. 51. Cha KY, Wirth DP, Lobo RA: Does prayer influence the success of in
25. Cabrera C: Holistic treatment of fibroids. Medical Herbalism 5:2-4, vitro fertilization–embryo transfer? Report of a masked, randomized
1993. trial. J Reprod Med 46:781-787, 2001.